Skip to main navigation Skip to search Skip to main content

Rimonabant redux and strategies to improve the future outlook of cb1 receptor neutral-antagonist/inverse-agonist therapies

  • Temple University

Research output: Contribution to journal › Review article › peer-review

46 Scopus citations
Original languageEnglish
Pages (from-to)1325-1334
Number of pages10
JournalObesity
Volume19
Issue number7
DOIs
StatePublished - Jul 2011
Externally publishedYes

Fingerprint

Dive into the research topics of 'Rimonabant redux and strategies to improve the future outlook of cb1 receptor neutral-antagonist/inverse-agonist therapies'. Together they form a unique fingerprint.

Cite this